Clinical trial
Tolerability of Sedation With Remimazolam Versus Midazolam in Outpatients Undergoing Upper GI or Biliopancreatic Endoscopic Ultrasound in a Non-Anesthesiologist Setting: A Prospective Observational Study (REM-EUS Study)
NCT07600073 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale di Lecco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability of Sedation With Remimazolam Versus Midazolam in Outpatients Undergoing Upper GI or Biliopancreatic Endoscopic Ultrasound in a Non-Anesthesiologist Setting: A Prospective Observational Study (REM-EUS Study)
- Lead sponsor
- Azienda Socio Sanitaria Territoriale di Lecco
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2026
- Completion date
- August 15, 2026
- Enrollment
- 126 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sedation during gi endoscopy